Experimental evidence of ω -3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: Their potential role in inflammatory, neurodegenerative, and neoplastic diseases

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Calviello, Gabriella ^a   Su, Hui Min ^b   Weylandt, Karsten H ^c   Fasano, Elena ^a   Serini, Simona ^a   Cittadini, Achille ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DOCOSAHEXAENOIC ACID; GAMMA INTERFERON; GELATINASE B; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE; LINOLENIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; OMEGA 3 FATTY ACID; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; LIPID;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; COLITIS; CYTOKINE RESPONSE; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FATTY ACID OXIDATION; HUMAN; INFLAMMATION; MACROPHAGE; METABOLIC DISORDER; NEOPLASM; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; ANIMAL; CHEMISTRY; METABOLISM; NEOPLASMS; NERVE DEGENERATION;

ANIMALS; CYTOKINES; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; NEOPLASMS; NERVE DEGENERATION;

EID: 84877252654     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/743171     Document Type: Review

References (145)

1. Delgado-Lista J., Perez-Martinez P., Lopez-Miranda J., Perez-Jimenez F., Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. British Journal of Nutrition 2012 107 2, supplement S201 S213
2. Baum S. J., Kris-Etherton P. M., Willett W. C., Lichtenstein A. H., Rudel L. L., Maki K. C., Whelan J., Ramsden C. E., Block R. C., Fatty acids in cardiovascular health and disease: a comprehensive update. Journal of Clinical Lipidology 2012 6 3 216 234
3. Calviello G., Serini S., Palozza P., n-3 polyunsaturated fatty acids as signal transduction modulators and therapeutical agents in cancer. Current Signal Transduction Therapy 2006 1 255 271
4. Calviello G., Serini S., Piccioni E., Pessina G., Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutrition and Cancer 2009 61 3 287 301 2-s2.0-67649396491 10.1080/01635580802582777
5. Calviello G., Serini S., Piccioni E., Alzheimer's disease and n-3 polyunsaturated fatty acids: beneficial effects and possible molecular pathways involved. Current Signal Transduction Therapy 2008 3 3 152 157 2-s2.0-54849422618 10.2174/157436208785699659
6. Su H. M., Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. Journal of Nutritional Biochemistry 2010 21 5 364 373 2-s2.0-77951620202 10.1016/j.jnutbio.2009.11.003
7. Sawyer M. B., Field C. J., Calviello G., Serini S., Albini A., Possible mechanism of ω -3PUFA anti-tumor action. Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer 2010 1 London, UK Springer 3 27 Diet and Cancer
8. Fasano E., Serini S., Piccioni E., Calviello G., Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids. Current Medicinal Chemistry 2010 17 29 3358 3376 2-s2.0-77957935855 0929-8673/10$55.00+.00
9. Calder P. C., Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? British Journal of Clinical Pharmacology 2013 75 3 645 662
10. Miles E. A., Calder P. C., Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. British Journal of Nutrition 2012 107 2, supplement S171 S184
11. Belluzzi A., n-3 fatty acids for the treatment of inflammatory bowel diseases. Proceedings of the Nutrition Society 2002 61 3 391 395 2-s2.0-0036692072 10.1079/PNS2002171 (Pubitemid 34982930)
12. Cabré E., Mañosa M., Gassull M. A., Omega-3 fatty acids and inflammatory bowel diseases-a systematic review. British Journal of Nutrition 2012 107 2, supplement S240 S252
13. McPherson R., Davies R. W., Inflammation and coronary artery disease: insights from genetic studies. Canadian Journal of Cardiology 2012 28 6 662 666
14. Després J. P., Abdominal obesity and cardiovascular disease: is inflammation the missing link? Canadian Journal of Cardiology 2012 28 6 642 652
15. Verri M., Pastoris O., Dossena M., Aquilani R., Guerriero F., Cuzzoni G., Venturini L., Ricevuti G., Bongiorno A. I., Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease. International Journal of Immunopathology & Pharmacology 2012 25 2 345 353
16. Porta C., Larghi P., Rimoldi M., Grazia Totaro M., Allavena P., Mantovani A., Sica A., Cellular and molecular pathways linking inflammation and cancer. Immunobiology 2009 214 9-10 761 777 2-s2.0-68349121579 10.1016/j.imbio.2009.06. 014
17. Anderson B. M., Ma D. W. L., Are all n-3 polyunsaturated fatty acids created equal? Lipids in Health and Disease 2009 8, article 33 2-s2.0-69549138351 10.1186/1476-511X-8-33
18. Su H. M., Moser A. B., Moser H. W., Watkins P. A., Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis. Journal of Biological Chemistry 2001 276 41 38115 38120 2-s2.0-0035851141
19. Hussein N., Ah-Sing E., Wilkinson P., Leach C., Griffin B. A., Millward D. J., Long-chain conversion of [13C]linoleic acid and α -linolenic acid in response to marked changes in their dietary intake in men. Journal of Lipid Research 2005 46 2 269 280 2-s2.0-13944270939 10.1194/jlr.M400225-JLR200 (Pubitemid 40271091)
20. Weylandt K. H., Chiu C. Y., Gomolka B., Waechter S. F., Wiedenmann B., Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins & Other Lipid Mediators 2012 97 3-4 73 82
21. Weylandt K. H., Kang J. X., Rethinking lipid mediators. Lancet 2005 366 9486 618 620 2-s2.0-23844478668 10.1016/S0140-6736(05)67119-X (Pubitemid 41176007)
22. Lukiw W. J., Cui J. G., Marcheselli V. L., Bodker M., Botkjaer A., Gotlinger K., Serhan C. N., Bazan N. G., A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. Journal of Clinical Investigation 2005 115 10 2774 2783 2-s2.0-26444598506 10.1172/JCI25420 (Pubitemid 41434404)
23. Mukherjee P. K., Marcheselli V. L., Vaccari J. C. D. R., Gordon W. C., Jackson F. E., Bazan N. G., Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proceedings of the National Academy of Sciences of the United States of America 2007 104 32 13158 13163 2-s2.0-34548742176 10.1073/pnas.0705963104 (Pubitemid 351737609)
24. Kang J. X., Wang J., Wu L., Kang Z. B., Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004 427 6974 504 2-s2.0-1442358602 (Pubitemid 38209102)
25. Hudert C. A., Weylandt K. H., Lu Y., Wang J., Hong S., Dignass A., Serhan C. N., Kang J. X., Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proceedings of the National Academy of Sciences of the United States of America 2006 103 30 11276 11281 2-s2.0-33746625086 10.1073/pnas.0601280103 (Pubitemid 44156509)
26. Gravaghi C., La Perle K. M. D., Ogrodwski P., Kang J. X., Quimby F., Lipkin M., Lamprecht S. A., Cox-2 expression, PGE2 and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice. Journal of Nutritional Biochemistry 2011 22 4 360 365 2-s2.0-78751520397 10.1016/j.jnutbio.2010.03.003
27. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M., Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. New England Journal of Medicine 1996 334 24 1557 1560 2-s2.0-0029992279 10.1056/NEJM199606133342401 (Pubitemid 26177482)
28. Feagan B. G., Sandborn W. J., Mittmann U., Bar-Meir S., D'Haens G., Bradette M., Cohen A., Dallaire C., Ponich T. P., McDonald J. W. D., Hébuterne X., Paré P., Klvana P., Niv Y., Ardizzone S., Alexeeva O., Rostom A., Kiudelis G., Spleiss J., Gilgen D., Vandervoort M. K., Wong C. J., Guang Y. Z., Donner A., Rutgeerts P., Omega-3 free fatty acids for the maintenance of remission in crohn disease: the EPIC randomized controlled trials. Journal of the American Medical Association 2008 299 14 1690 1697 2-s2.0-41949118078 10.1001/jama.299.14.1690 (Pubitemid 351519866)
29. Turner D., Steinhart A. H., Griffiths A. M., Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2007 3 CD006443 2-s2.0-35348818919
30. Schmöcker C., Weylandt K. H., Kahlke L., Wang J., Lobeck H., Tiegs G., Berg T., Kang J. X., Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 2007 45 4 864 869 2-s2.0-34247326379 10.1002/hep.21626 (Pubitemid 46631554)
31. Weylandt K. H., Krause L. F., Gomolka B., Chiu C. Y., Bilal S., Nadolny A., Waechter S. F., Fischer A., Rothe M., Kang J. X., Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF- α Carcinogenesis 2011 32 6 897 903 2-s2.0-79958204979 10.1093/carcin/bgr049
32. González-Périz A., Planagumà A., Gronert K., Miquel R., López-Parra M., Titos E., Horrillo R., Ferré N., Deulofeu R., Arroyo V., Rodés J., Clària J., Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. The FASEB Journal 2006 20 14 2537 2539 2-s2.0-33947505559 10.1096/fj.06-6250fje (Pubitemid 44953772)
33. Kim E. H., Bae J. S., Hahm K. B., Cha J. Y., Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease. Biochemical Pharmacology 2012 84 10 1359 1365
34. González-Périz A., Horrillo R., Ferré N., Gronert K., Dong B., Morán-Salvador E., Titos E., Martínez-Clemente M., López-Parra M., Arroyo V., Clària J., Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω -3 fatty acids: a role for resolvins and protectins. FASEB Journal 2009 23 6 1946 1957 2-s2.0-67649363782 10.1096/fj.08-125674
35. Le H. D., de Meijer V. E., Robinson E. M., Zurakowski D., Potemkin A. K., Arsenault D. A., Fallon E. M., Malkan A., Bistrian B. R., Gura K. M., Puder M., Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. The American Journal of Clinical Nutrition 2011 94 3 749 758
36. Glueck C. J., Khan N., Riaz M., Padda J., Khan Z., Wang P., Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels >500 mg/dl despite conventional triglyceride lowering therapy. Lipids in Health and Disease 2012 11 143
37. Harris W. S., Rothrock D. W., Fanning A., Inkeles S. B., Goodnight S. H., Illingworth D. R., Connor W. E., Fish oils in hypertriglyceridemia: a dose-response study. American Journal of Clinical Nutrition 1990 51 3 399 406 2-s2.0-0025348975
38. Phillipson B. E., Rothrock D. W., Connor W. E., Harris W. S., Illingworth D. R., Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. New England Journal of Medicine 1985 312 19 1210 1216 2-s2.0-0021821575 (Pubitemid 15009154)
39. Lindkvist B., Appelros S., Regner S., Manjer J., A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose. Pancreatology 2012 12 4 317 324
40. Murad M. H., Hazem A., Coto-Yglesias F., Dzyubak S., Gupta S., Bancos I., Lane M. A., Erwin P. J., Berglund L., Elraiyah T., Montori V. M., The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis. BMC Endocrine Disorders 2012 12, article 2
41. Weylandt K. H., Nadolny A., Kahlke L., Köhnke T., Schmöcker C., Wang J., Lauwers G. Y., Glickman J. N., Kang J. X., Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis. Biochimica et Biophysica Acta 2008 1782 11 634 641 2-s2.0-55049106624 10.1016/j.bbadis.2008.08.011
42. Lasztity N., Hamvas J., Biró L., Németh É., Marosvölgyi T., Decsi T., Pap Á., Antal M., Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis-a prospective randomized clinical trial. Clinical Nutrition 2005 24 2 198 205 2-s2.0-15344347513 10.1016/j.clnu.2004.12.008 (Pubitemid 40392802)
43. Wang X., Li W., Li N., Li J., ω -3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. Journal of Parenteral and Enteral Nutrition 2008 32 3 236 241 2-s2.0-42449124532 10.1177/0148607108316189 (Pubitemid 351571258)
44. Puri P., Baillie R. A., Wiest M. M., Mirshahi F., Choudhury J., Cheung O., Sargeant C., Contos M. J., Sanyal A. J., A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007 46 4 1081 1090 2-s2.0-36349024819 10.1002/hep.21763 (Pubitemid 350144772)
45. Puri P., Wiest M. M., Cheung O., Mirshahi F., Sargeant C., Min H. K., Contos M. J., Sterling R. K., Fuchs M., Zhou H., Watkins S. M., Sanyal A. J., The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009 50 6 1827 1838 2-s2.0-73149094543 10.1002/hep.23229
46. Gomolka B., Siegert E., Blossey K., Schunck W. H., Rothe M., Weylandt K. H., Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. Prostaglandins and Other Lipid Mediators 2011 94 3-4 81 87 2-s2.0-79954422010 10.1016/j.prostaglandins.2010.12. 006
47. Sastry P. S., Lipids of nervous tissue: composition and metabolism. Progress in Lipid Research 1985 24 2 69 176 2-s2.0-0022302720
48. Dobbing J., Sands J., Comparative aspects of the brain growth spurt. Early Human Development 1979 3 1 79 83 2-s2.0-0018372689 (Pubitemid 9141710)
49. Green P., Glozman S., Kamensky B., Yavin E., Developmental changes in rat brain membrane lipids and fatty acids: the preferential prenatal accumulation of docosahexaenoic acid. Journal of Lipid Research 1999 40 5 960 966 2-s2.0-0032896017 (Pubitemid 29220538)
50. Martinez M., Tissue levels of polyunsaturated fatty acids during early human development. Journal of Pediatrics 1992 120 4 129 138 2-s2.0-0026534480
51. Favrelière S., Stadelmann-Ingrand S., Huguet F., De Javel D., Piriou A., Tallineau C., Durand G., Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiology of Aging 2000 21 5 653 660 2-s2.0-0034282175 10.1016/S0197-4580(00) 00170-6
52. Delion S., Chalon S., Guilloteau D., Lejeune B., Besnard J. C., Durand G., Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. Journal of Lipid Research 1997 38 4 680 689 2-s2.0-0030948048 (Pubitemid 27194919)
53. Soderberg M., Edlund C., Kristensson K., Dallner G., Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991 26 6 421 425 2-s2.0-0025913434
54. Prasad M. R., Lovell M. A., Yatin M., Dhillon H., Markesbery W. R., Regional membrane phospholipid alterations in Alzheimer's disease. Neurochemical Research 1998 23 1 81 88 2-s2.0-0031942410 10.1023/A:1022457605436 (Pubitemid 28145695)
55. Chung W. L., Chen J. J., Su H. M., Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. Journal of Nutrition 2008 138 6 1165 1171 2-s2.0-44449091066
56. Tully A. M., Roche H. M., Doyle R., Fallon C., Bruce I., Lawlor B., Coakley D., Gibney M. J., Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. British Journal of Nutrition 2003 89 4 483 489 2-s2.0-0037650162 10.1079/BJN2002804 (Pubitemid 36582118)
57. Scott B. L., Bazan N. G., Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proceedings of the National Academy of Sciences of the United States of America 1989 86 8 2903 2907 2-s2.0-0039369595 (Pubitemid 19112648)
58. Green P., Yavin E., Elongation, desaturation, and esterification of essential fatty acids by fetal rat brain in vivo. Journal of Lipid Research 1993 34 12 2099 2107 2-s2.0-0027143636 (Pubitemid 24000958)
59. Su H. M., Huang M. C., Saad N. M. R., Nathanielsz P. W., Brenna J. T., Fetal baboons convert 18:3n-3 to 22:6n-3 in vivo: a stable isotope tracer study. Journal of Lipid Research 2001 42 4 581 586 2-s2.0-0035063527 (Pubitemid 32367001)
60. Williams C. M., Burdge G., Long-chain n-3 PUFA: plant v. marine sources. Proceedings of the Nutrition Society 2006 65 1 42 50 2-s2.0-32944467555 10.1079/PNS2005473 (Pubitemid 43259983)
61. Brenna J. T., Salem N. Jr., Sinclair A. J., Cunnane S. C., α -Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukotrienes and Essential Fatty Acids 2009 80 2-3 85 91 2-s2.0-61849141189 10.1016/j.plefa.2009.01.004
62. Mukherjee P. K., Marcheselli V. L., Serhan C. N., Bazan N. G., Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2004 101 22 8491 8496 2-s2.0-2942625603 10.1073/pnas.0402531101 (Pubitemid 38736602)
63. Kim H. Y., Akbar M., Lau A., Edsall L., Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3): role of phosphatidylserine in antiapoptotic effect. Journal of Biological Chemistry 2000 275 45 35215 35223 2-s2.0-0034634590 10.1074/jbc.M004446200
64. Akbar M., Kim H. Y., Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. Journal of Neurochemistry 2002 82 3 655 665 2-s2.0-0036326587 10.1046/j.1471-4159.2002.01015.x (Pubitemid 34831503)
65. Akbar M., Calderon F., Wen Z., Kim H. Y., Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proceedings of the National Academy of Sciences of the United States of America 2005 102 31 10858 10863 2-s2.0-23344439553 10.1073/pnas.0502903102 (Pubitemid 41105957)
66. Rotstein N. P., Politi L. E., German O. L., Girotti R., Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Investigative Ophthalmology and Visual Science 2003 44 5 2252 2259 2-s2.0-0037407743 10.1167/iovs.02-0901 (Pubitemid 36520324)
67. Rotstein N. P., Aveldańo M. I., Barrantes F. J., Roccamo A. M., Politi L. E., Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. Journal of Neurochemistry 1997 69 2 504 513 2-s2.0-0030807556 (Pubitemid 27327951)
68. Lauritzen I., Blondeau N., Heurteaux C., Widmann C., Romey G., Lazdunski M., Polyunsaturated fatty acids are potent neuroprotectors. EMBO Journal 2000 19 8 1784 1793 2-s2.0-0034678889 (Pubitemid 30204390)
69. Lynch A. M., Loane D. J., Minogue A. M., Clarke R. M., Kilroy D., Nally R. E., Roche Ó. J., O'Connell F., Lynch M. A., Eicosapentaenoic acid confers neuroprotection in the amyloid- β challenged aged hippocampus. Neurobiology of Aging 2007 28 6 845 855 2-s2.0-34247157293 10.1016/j. neurobiolaging.2006.04.006 (Pubitemid 46589740)
70. Walsh D. M., Selkoe D. J., A β oligomers-a decade of discovery. Journal of Neurochemistry 2007 101 5 1172 1184 2-s2.0-34248190279 10.1111/j.1471-4159.2006.04426.x (Pubitemid 46718812)
71. Mulder C., Scheltens P., Visser J. J., Van Kamp G. J., Schutgens R. B. H., Genetic and biochemical markers for Alzheimer's disease: recent developments. Annals of Clinical Biochemistry 2000 37 5 593 607 2-s2.0-0033813526
72. Rapoport M., Dawson H. N., Binder L. I., Vitek M. P., Ferreira A., Tau is essential to β -amyloid-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 2002 99 9 6364 6369 2-s2.0-0037197836 10.1073/pnas.092136199 (Pubitemid 34493317)
73. Spires T. L., Hyman B. T., Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2005 2 3 423 437 2-s2.0-26844449402 10.1602/neurorx.2.3.423 (Pubitemid 41444876)
74. Braak H., Braak E., Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiology of Aging 1997 18 4 351 357 2-s2.0-0030805991 10.1016/S0197-4580(97)00056-0 (Pubitemid 27435070)
75. Hossain S., Hashimoto M., Katakura M., Miwa K., Shimada T., Shido O., Mechanism of docosahexaenoic acid-induced inhibition of in vitro A β 1-42 fibrillation and A β 1-42-induced toxicity in SH-S5Y5 cells. Journal of Neurochemistry 2009 111 2 568 579 2-s2.0-70349311725 10.1111/j.1471-4159.2009. 06336.x
76. Zhao Y., Calon F., Julien C., Winkler J. W., Petasis N. A., Lukiw W. J., Bazan N. G., Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR γ -mediated mechanisms in Alzheimer's disease models. PLoS ONE 2011 6 1 2-s2.0-79251559674 10.1371/journal.pone. 0015816 e15816
77. Mukherjee P. K., Marcheselli V. L., Barreiro S., Hu J., Bok D., Bazan N. G., Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proceedings of the National Academy of Sciences of the United States of America 2007 104 32 13152 13157 2-s2.0-34548711717 10.1073/pnas.0705949104 (Pubitemid 351737608)
78. Lim G. P., Calon F., Morihara T., Yang F., Teter B., Ubeda O., Salem N., Frautschy S. A., Cole G. M., A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. Journal of Neuroscience 2005 25 12 3032 3040 2-s2.0-16244416174 10.1523/JNEUROSCI.4225-04.2005 (Pubitemid 40463537)
79. Green K. N., Martinez-Coria H., Khashwji H., Hall E. B., Yurko-Mauro K. A., Ellis L., LaFerla F. M., Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid- β and tau pathology via a mechanism involving presenilin 1 levels. Journal of Neuroscience 2007 27 16 4385 4395 2-s2.0-34247380762 10.1523/JNEUROSCI.0055-07.2007 (Pubitemid 46640724)
80. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J. I., Shido O., Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. Journal of Neurochemistry 2002 81 5 1084 1091 2-s2.0-0036319034 10.1046/j.1471-4159.2002. 00905.x (Pubitemid 34809291)
81. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., Shido O., Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid β -infused rats. Journal of Nutrition 2005 135 3 549 555 2-s2.0-14944376646 (Pubitemid 40365217)
82. Hashimoto M., Hossain S., Tanabe Y., Kawashima A., Harada T., Yano T., Mizuguchi K., Shido O., The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid β (1-40). Journal of Nutritional Biochemistry 2009 20 12 965 973 2-s2.0-71649091172 10.1016/j.jnutbio.2008.08.009
83. Calon F., Lim G. P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem N., Ashe K. H., Frautschy S. A., Cole G. M., Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004 43 5 633 645 2-s2.0-4444223956 10.1016/j.neuron.2004. 08.013 (Pubitemid 39179724)
84. Freund-Levi Y., Eriksdotter-Jönhagen M., Cederholm T., Basun H., Faxén-Irving G., Garlind A., Vedin I., Vessby B., Wahlund L. O., Palmblad J., ω -3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: omegAD study-a randomized double-blind trial. Archives of Neurology 2006 63 10 1402 1408 2-s2.0-33749633921 10.1001/archneur.63.10.1402 (Pubitemid 44547551)
85. Vedin I., Cederholm T., Levi Y. F., Basun H., Garlind A., Irving G. F., Jönhagen M. E., Vessby B., Wahlund L. O., Palmblad J., Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. American Journal of Clinical Nutrition 2008 87 6 1616 1622 2-s2.0-45749114465 (Pubitemid 351872622)
86. Vedin I., Cederholm T., Freund-Levi Y., Basun H., Hjorth E., Irving G. F., Eriksdotter-Jönhagen M., Schultzberg M., Wahlund L. O., Palmblad J., Reduced prostaglandin F2 α release from blood mononuclear leukocytes after oral supplementation of ω 3 fatty acids: the OmegAD study. Journal of Lipid Research 2010 51 5 1179 1185 2-s2.0-77951085015 10.1194/jlr.M002667
87. Vedin I., Cederholm T., Levi Y. F., Basun H., Garlind A., Irving G. F., Jönhagen M. E., Vessby B., Wahlund L. O., Palmblad J., Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study. PLoS ONE 2012 7 4 e35425
88. Freund-Levi Y., Hjorth E., Lindberg C., Cederholm T., Faxen-Irving G., Vedin I., Palmblad J., Wahlund L. O., Schultzberg M., Basun H., Eriksdotter Jönhagen M., Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in alzheimer's disease: the omegad study. Dementia and Geriatric Cognitive Disorders 2009 27 5 481 490 2-s2.0-65549164405 10.1159/000218081
89. Beydoun M. A., Kaufman J. S., Satia J. A., Rosamond W., Folsom A. R., Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the atherosclerosis risk in communities study. American Journal of Clinical Nutrition 2007 85 4 1103 1111 2-s2.0-34147107925 (Pubitemid 46557928)
90. Whalley L. J., Deary I. J., Starr J. M., Wahle K. W., Rance K. A., Bourne V. J., Fox H. C., n-3 Fatty acid erythrocyte membrane content, APOE ε 4, and cognitive variation: an observational follow-up study in late adulthood. American Journal of Clinical Nutrition 2008 87 2 449 454 2-s2.0-38949110024 (Pubitemid 351226084)
91. Boudrault C., Bazinet R. P., Ma D. W. L., Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. Journal of Nutritional Biochemistry 2009 20 1 1 10 2-s2.0-57049137646 10.1016/j.jnutbio.2008.05.016
92. Hashimoto M., Yamashita K., Kato S., Tamai T., Tanabe Y., Mitarai M., Matsumoto I., Ohno M., " " Beneficial effects of dietary omega-3 polyunsaturated fatty acid supplementation on age-related cognitive decline in elder Japanese with very mild dementia: a 2-year randomized, double-blind, placebo-controlled trial. Journal of Aging Research and Clinical Practice 2012 1 3 193 201
93. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation. Nature 2008 454 7203 436 444 2-s2.0-47949096781 10.1038/nature07205
94. Janakiram N. B., Mohammed A., Rao C. V., Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer and Metastasis Reviews 2011 30 3-4 507 523
95. Berasain C., Perugorria M. J., Latasa M. U., Castillo J., Goñi S., Santamaría M., Prieto J., Avila M. A., The epidermal growth factor receptor: a link between inflammation and liver cancer. Experimental Biology and Medicine 2009 234 7 713 725 2-s2.0-67650227488 10.3181/0901-MR-12
96. Balkwill F. R., Mantovani A., Cancer-related inflammation: common themes and therapeutic opportunities. Seminars in Cancer Biology 2012 22 1 33 40
97. Manzano A A., Pérez-Segura P., Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention? ScientificWorldJournal 2012 2012 8 10.1100/2012/327341 327341
98. Kamp D. W., Shacter E., Weitzman S. A., Chronic inflammation and cancer: the role of the mitochondria. Oncology 2011 25 5 400 413 2-s2.0-79960149868
99. Ohshima H., Tazawa H., Sylla B. S., Sawa T., Prevention of human cancer by modulation of chronic inflammatory processes. Mutation Research 2005 591 1-2 110 122 2-s2.0-27844562225 10.1016/j.mrfmmm.2005.03.030 (Pubitemid 41654843)
100. Sica A., Larghi P., Mancino A., Rubino L., porta C., Totaro M. G., Rimoldi M., Biswas S. K., Allavena P., Mantovani A., Macrophage polarization in tumour progression. Seminars in Cancer Biology 2008 18 5 349 355 2-s2.0-48349102876 10.1016/j.semcancer.2008.03.004
101. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology 2002 23 11 549 555 2-s2.0-0036839143 10.1016/S1471-4906(02)02302-5 (Pubitemid 35223554)
102. Saw C. L. L., Huang Y., Kong A. N., Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid. Biochemical Pharmacology 2010 79 3 421 430 2-s2.0-70449657770 10.1016/j.bcp.2009.08.030
103. Monk J. M., Hou T. Y., Turk H. F., Weeks B., Wu C., McMurray D. N., Chapkin R. S., Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis. PLoS ONE 2012 7 11 e49739
104. Brown A. L., Zhu X., Rong S., Shewale S., Seo J., Boudyguina E., Gebre A. K., Alexander-Miller M. A., Parks J. S., Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions. Arteriosclerosis, Thrombosis and Vascular Biology 2012 32 9 2122 2130
105. Calviello G., Serini S., Calviello G., Serini S., Albini A., ω -3 PUFAs, why are we speaking of them? Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer 2010 1 London, UK Springer 9 21 Diet and Cancer
106. Finocchiaro C., Segre O., Fadda M., Monge T., Scigliano M., Schena M., Tinivella M., Tiozzo E., Catalano M. G., Pugliese M., Fortunati N., Aragno M., Muzio G., Maggiora M., Oraldi M., Canuto R. A., Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. British Journal of Nutrition 2012 108 2 327 333
107. Zhu M. W., Tang D. N., Hou J., Wei J. M., Hua B., Sun J. H., Cui H. Y., Impact of fish oil enriched total parenteral nutrition on elderly patients after colorectal cancer surgery. Chinese Medicine Journal 2012 125 2 178 181
108. Read J. A., Beale P. J., Volker D. H., Smith N., Childs A., Clarke S. J., Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Supportive Care in Cancer 2007 15 3 301 307 2-s2.0-33847122540 10.1007/s00520-006-0153-3 (Pubitemid 46295216)
109. Lou Y. R., Peng Q. Y., Li T., Medvecky C. M., Lin Y., Shih W. J., Conney A. H., Shapses S., Wagner G. C., Lu Y. P., Effects of high-fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis 2011 32 7 1078 1084 2-s2.0-79960033324 10.1093/carcin/bgr074
110. Park K. S., Lim J. W., Kim H., Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis. Annals of the New York Academy of Sciences 2009 1171 421 427 2-s2.0-69149087639 10.1111/j.1749-6632.2009.04887. x
111. Rosa D. D., Lourenço F. C., da Fonseca A. C., Fish oil improves the lipid profile and reduces inflammatory cytokines in Wistar rats with precancerous colon lesions. Nutrition and Cancer 2012 64 4 569 579
112. Serini S., Piccioni E., Calviello G., Calviello G., Serini S., Albini A., ω -3 PUFAs and colon cancer: experimental studies and human interventional trials. Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer 2010 1 London, UK Springer 67 89 Diet and Cancer
113. Ibrahim A., Mbodji K., Hassan A., Aziz M., Boukhettala N., Coëffier M., Savoye G., Déchelotte P., Marion-Letellier R., Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium. Clinical Nutrition 2011 30 5 678 687
114. Calviello G., Di Nicuolo F., Gragnoli S., Piccioni E., Serini S., Maggiano N., Triangali G., Navarra P., Ranelletti F. O., Palozza P., n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1 α induction pathway. Carcinogenesis 2004 25 12 2303 2310 2-s2.0-10344263374 10.1093/carcin/bgh265 (Pubitemid 39625169)
115. Storey A., McArdle F., Friedmann P. S., Jackson M. J., Rhodes L. E., Eicosapentaenoic acid and docosahexaenoic acid reduce UVB- and TNF- α -induced IL-8 secretion in keratinocytes and UVB-induced IL-8 in fibroblasts. Journal of Investigative Dermatology 2005 124 1 248 255 2-s2.0-11944255887 10.1111/j.0022-202X.2004.23543.x (Pubitemid 40100976)
116. Bögels M., Braster R., Nijland P. G., Gül N., van de Luijtgaarden W., Fijneman R. J., Meijer G. A., Jimenez C. R., Beelen R. H., van Egmond M., Carcinoma origin dictates differential skewing of monocyte function. Oncoimmunology 2012 1 6 798 809
117. Chiu C. Y., Gomolka B., Dierkes C., Huang N. R., Schroeder M., Purschke M., Manstein D., Dangi B., Weylandt K. H., Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Inflammation Research 2012 61 9 967 976
118. Dolcet X., Llobet D., Pallares J., Matias-Guiu X., NF-kB in development and progression of human cancer. Virchows Archiv 2005 446 5 475 482 2-s2.0-21244496344 10.1007/s00428-005-1264-9 (Pubitemid 40884279)
119. Pikarsky E., Porat R. M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Uriell-Shoval S., Galun E., Ben-Neriah Y., NF- B functions as a tumour promoter in inflammation-associated cancer. Nature 2004 431 7007 461 466 2-s2.0-4644324186 10.1038/nature02924 (Pubitemid 39329586)
120. Saccani A., Schioppa T., Porta C., Biswas S. K., Nebuloni M., Vago L., Bottazzi B., Colombo M. P., Mantovani A., Sica A., p50 nuclear factor- B overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Research 2006 66 23 11432 11440 2-s2.0-33845752914 10.1158/0008-5472.CAN-06-1867 (Pubitemid 46009975)
121. Nowak J., Weylandt K. H., Habbel P., Wang J., Dignass A., Glickman J. N., Kang J. X., Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids. Carcinogenesis 2007 28 9 1991 1995 2-s2.0-34848875143 10.1093/carcin/bgm166 (Pubitemid 47500613)
122. Jia Q., Lupton J. R., Smith R., Weeks B. R., Callaway E., Davidson L. A., Kim W., Fan Y. Y., Yang P., Newman R. A., Kang J. X., McMurray D. N., Chapkin R. S., Reduced colitis-associated colon cancer in fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Research 2008 68 10 3985 3991 2-s2.0-45549085184 10.1158/0008-5472.CAN-07-6251
123. Griffitts J., Saunders D., Tesiram Y. A., Reid G. E., Salih A., Liu S., Lydic T. A., Busik J. V., Kang J. X., Towner R. A., Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model. Omega-3 fatty acids prevent liver neoplasia. Biochimica et Biophysica Acta 2010 1801 10 1133 1144 2-s2.0-77955513412 10.1016/j.bbalip.2010.06.008
124. Sethi G., Shanmugam M. K., Ramachandran L., Kumar A. P., Tergaonkar V., Multifaceted link between cancer and inflammation. Bioscience Reports 2012 32 1 1 15
125. Serini S., Donato V., Piccioni E., Trombino S., Monego G., Toesca A., Innocenti I., Missori M., De Spirito M., Celleno L., Fasano E., Ranelletti F. O., Calviello G., Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. Journal of Nutritional Biochemistry 2011 22 9 874 885
126. Serini S., Fasano E., Piccioni E., Monego G., Cittadini A. R., Celleno L., Ranelletti F. O., Calviello G., DHA induces apoptosis and differentiation in human melanoma cells in vitro: involvement of HuR-mediated COX-2 mRNA stabilization and β -catenin nuclear translocation. Carcinogenesis 2012 33 1 164 173
127. Solinas G., Marchesi F., Garlanda C., Mantovani A., Allavena P., Inflammation-mediated promotion of invasion and metastasis. Cancer and Metastasis Reviews 2010 29 2 243 248 2-s2.0-77954565039 10.1007/s10555-010-9227- 2
128. Giavazzi R., Garofalo A., Bani M. R., Abbate M., Ghezzi P., Boraschi D., Mantovani A., Dejana E., Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Research 1990 50 15 4771 4775 2-s2.0-0025311435 (Pubitemid 20230427)
129. Kim H. H., Lee Y., Eun H. C., Chung J. H., Eicosapentaenoic acid inhibits TNF- α -induced matrix metalloproteinase-9 expression in human keratinocytes, HaCaT cells. Biochemical and Biophysical Research Communications 2008 368 2 343 349 2-s2.0-39549097949 10.1016/j.bbrc.2008.01.062
130. Bernhard E. J., Gruber S. B., Muschel R. J., Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proceedings of the National Academy of Sciences of the United States of America 1994 91 10 4293 4297 2-s2.0-0028346025 (Pubitemid 24143419)
131. Zucker S., Lysik R. M., Zarrabi M. H., Moll U., M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Research 1993 53 1 140 146 2-s2.0-0027388922 (Pubitemid 23019389)
132. Cao W., Ma Z., Rasenick M. M., Yeh S., Yu J., N-3 poly-unsaturated Fatty acids shift estrogen signaling to inhibit human breast cancer cell growth. PLoS ONE 2012 7 12 e52838
133. Rogers K. R., Kikawa K. D., Mouradian M., Hernandez K., McKinnon K. M., Ahwah S. M., Pardini R. S., Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 2010 31 9 1523 1530 2-s2.0-77956295532 10.1093/carcin/bgq111
134. Sharma A., Belna J., Espat J., Rodriguez G., Cannon V. T., Hurteau J. A., Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer. American Journal of Obstetrics and Gynecology 2009 200 5 516.e1 516.e6 2-s2.0-64249102520 10.1016/j.ajog.2008.12.023
135. Bitzer M., Von Gersdorff G., Liang D., Dominguez-Rosales A., Beg A. A., Rojkind M., Böttinger E. P., A mechanism of suppression of TGF- β /SMAD signaling by NF- B/RelA. Genes and Development 2000 14 2 187 197 2-s2.0-0034650266 (Pubitemid 30070984)
136. Calviello G., Serini S., Piccioni E., Pessina G., Antineoplastic effects of N-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutrition and Cancer 2009 61 3 287 301 2-s2.0-67649396491 10.1080/01635580802582777
137. Sawyer M. B., Field C. J., Calviello G., Serini S., Albini A., Possible mechanisms of omega-3 (n-3) PUFA anti-tumour action. Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer 2010 1 London, UK Springer 3 38 Diet and Cancer
138. Fasano E., Serini S., Piccioni E., Toesca A., Monego G., Cittadini A. R., Ranelletti F. O., Calviello G., DHA induces apoptosis by altering the expression and cellular location of GRP78 in colon cancer cell lines. Biochimica et Biophysica Acta 2012 1822 11 1762 1772
139. Serini S., Fasano E., Piccioni E., Cittadini A. R., Calviello G., Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved. Current Medicinal Chemistry 2011 18 26 4065 4075
140. Calviello G., Resci F., Serini S., Piccioni E., Toesca A., Boninsegna A., Monego G., Ranelletti F. O., Palozza P., Docosahexaenoic acid induces proteasome-dependent degradation of β -catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis 2007 28 6 1202 1209 2-s2.0-34447330713 10.1093/carcin/bgl254 (Pubitemid 47062678)
141. Stillwell W., Wassall S. R., Docosahexaenoic acid: membrane properties of a unique fatty acid. Chemistry and Physics of Lipids 2003 126 1 1 27 2-s2.0-0142059080 10.1016/S0009-3084(03)00101-4 (Pubitemid 37297962)
142. Anti M., Marra G., Armelao F., Bartoli G. M., Ficarelli R., Percesepe A., De Vitis I., Maria G., Sofo L., Rapaccini G. L., Gentiloni N., Piccioni E., Miggiano G., Effect of ω -3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992 103 3 883 891 2-s2.0-0026737310
143. Huang Y. C., Jessup J. M., Forse R. A., Flickner S., Pleskow D., Anastopoulos H. T., Ritter V., Blackburn G. L., n-3 fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa. Lipids 1996 31 3, supplement S313 S317 2-s2.0-0029926288
144. West N. J., Clark S. K., Phillips R. K. S., Hutchinson J. M., Leicester R. J., Belluzzi A., Hull M. A., Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 2010 59 7 918 925 2-s2.0-77953969298 10.1136/gut.2009.200642
145. Sawada N., Inoue M., Iwasaki M., Sasazuki S., Shimazu T., Yamaji T., Takachi R., Tanaka Y., Mizokami M., Tsugane S., Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology 2012 142 7 1468 1475